the original fmcg company deal, page-18

"One would not for a multi billion dollar drug announce that consumer testing was positive and publish the fact that one now moves onto marketing and manufacturing.
Such an ann would reveal not only the name of the company but also the deliverd drug which can not be in the interest of the FMCG, which needs to surprise competition, or at least maintain the strategic advantage coming from such an innovation."


I would have thought this would be material to the value of the sp and therefore due to asx rules need to be reported.


As for OBJ wanting to do the vitro and in vivo testing makes us look like the little dog barking at it's masters heals to take it for a walk. Looks like the FMCG are in two minds whether to take the technology on and we're begging them to go ahead with it. There'll probably be another capital raising for us to go testing on their behalf.

All in all the AGM presentation very much lacking in detail, as per usual with managements PR acumen.